concizumab-mtci
Brand: ALHEMO
approved
Quick answer
concizumab-mtci (ALHEMO), is a pharmaceutical active ingredient, with approved status in the US.
Key facts
- INN
- concizumab-mtci
- Brand
- ALHEMO
- Route
- SUBCUTANEOUS
- Formulation
- INJECTABLE
Frequently asked questions
What is concizumab-mtci?
concizumab-mtci (ALHEMO), is a pharmaceutical active ingredient, with approved status in the US.
What is the brand name for concizumab-mtci?
ALHEMO is a marketed brand name for concizumab-mtci. Check FDA Drugs@FDA for the current US label holder.